Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD — Rubaiyat Haque (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD
Shared by
Peter J Barnes
Imperial College London
Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD
Article
2013
en
Authors
+7 more
RH
Rubaiyat Haque
AH
Amir Hakim
TM
Thunicia Moodley
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Glucocorticoid Receptor Nuclear Translocation in Airway Cells after Inhaled Combination Therapy
Omar S. Usmani
,
Kazuhiro Ito
,
Kittipong Maneechotesuwan
,
Misako Ito
,
Malcolm Johnson
,
Peter J Barnes
,
Ian M. Adcock
Article
1996
Effect of short- and long-acting β2-adrenoceptor agonists on pulmonary β2-adrenoceptor expression in human lung
Masanori Nishikawa
,
Jcw Mak
,
Peter J Barnes
Article
2016
Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Amir Hakim
,
Younis Mohd Khan
,
Ignacio Esteban
,
Anna Miller‐Larsson
,
Peter J Barnes
,
Omar S. Usmani
Article
2010
Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid (ICS), With Sustained Glucocorticoid Receptor Nuclear Translocation
Kazuhiro Ito
,
Christos Rossios
,
Ian M. Adcock
,
Peter J Barnes
,
Malcolm Johnson
Article
1992
Questions about inhaled β2-adrenoceptor agonists in asthma
Peter J Barnes
,
Kian Fan Chung
Discussion(0)
No comments yet. Be the first to comment.